299 related articles for article (PubMed ID: 2809198)
1. Immunosuppression and transforming growth factor-beta in glioblastoma. Preferential production of transforming growth factor-beta 2.
Bodmer S; Strommer K; Frei K; Siepl C; de Tribolet N; Heid I; Fontana A
J Immunol; 1989 Nov; 143(10):3222-9. PubMed ID: 2809198
[TBL] [Abstract][Full Text] [Related]
2. Protease inhibitors interfere with the transforming growth factor-beta-dependent but not the transforming growth factor-beta-independent pathway of tumor cell-mediated immunosuppression.
Huber D; Philipp J; Fontana A
J Immunol; 1992 Jan; 148(1):277-84. PubMed ID: 1727872
[TBL] [Abstract][Full Text] [Related]
3. The glioblastoma-derived T cell suppressor factor/transforming growth factor-beta 2 inhibits T cell growth without affecting the interaction of interleukin 2 with its receptor.
Siepl C; Bodmer S; Frei K; MacDonald HR; De Martin R; Hofer E; Fontana A
Eur J Immunol; 1988 Apr; 18(4):593-600. PubMed ID: 2452745
[TBL] [Abstract][Full Text] [Related]
4. Differential expression of transforming growth factor-beta 1, -beta 2, and -beta 3 by glioblastoma cells, astrocytes, and microglia.
Constam DB; Philipp J; Malipiero UV; ten Dijke P; Schachner M; Fontana A
J Immunol; 1992 Mar; 148(5):1404-10. PubMed ID: 1538124
[TBL] [Abstract][Full Text] [Related]
5. Transforming growth factor-beta 2 down-regulates HLA-DR antigen expression on human malignant glioma cells.
Zuber P; Kuppner MC; De Tribolet N
Eur J Immunol; 1988 Oct; 18(10):1623-6. PubMed ID: 3142781
[TBL] [Abstract][Full Text] [Related]
6. Control of the expression of c-sis mRNA in human glioblastoma cells by phorbol ester and transforming growth factor beta 1.
Press RD; Misra A; Gillaspy G; Samols D; Goldthwait DA
Cancer Res; 1989 Jun; 49(11):2914-20. PubMed ID: 2655888
[TBL] [Abstract][Full Text] [Related]
7. Induction of transforming growth factor beta 1 and its receptors during all-trans-retinoic acid (RA) treatment of RA-responsive human neuroblastoma cell lines.
Cohen PS; Letterio JJ; Gaetano C; Chan J; Matsumoto K; Sporn MB; Thiele CJ
Cancer Res; 1995 Jun; 55(11):2380-6. PubMed ID: 7757990
[TBL] [Abstract][Full Text] [Related]
8. Increased expression of genes from growth factor signaling pathways in glioblastoma cell lines.
Saxena A; Ali IU
Oncogene; 1992 Feb; 7(2):243-7. PubMed ID: 1347915
[TBL] [Abstract][Full Text] [Related]
9. Differential expression of transforming growth factor beta receptors in human pancreatic adenocarcinoma.
Venkatasubbarao K; Ahmed MM; Mohiuddin M; Swiderski C; Lee E; Gower WR; Salhab KF; McGrath P; Strodel W; Freeman JW
Anticancer Res; 2000; 20(1A):43-51. PubMed ID: 10769633
[TBL] [Abstract][Full Text] [Related]
10. RNA interference targeting transforming growth factor-beta enhances NKG2D-mediated antiglioma immune response, inhibits glioma cell migration and invasiveness, and abrogates tumorigenicity in vivo.
Friese MA; Wischhusen J; Wick W; Weiler M; Eisele G; Steinle A; Weller M
Cancer Res; 2004 Oct; 64(20):7596-603. PubMed ID: 15492287
[TBL] [Abstract][Full Text] [Related]
11. Microglia-derived TGF-beta as an important regulator of glioblastoma invasion--an inhibition of TGF-beta-dependent effects by shRNA against human TGF-beta type II receptor.
Wesolowska A; Kwiatkowska A; Slomnicki L; Dembinski M; Master A; Sliwa M; Franciszkiewicz K; Chouaib S; Kaminska B
Oncogene; 2008 Feb; 27(7):918-30. PubMed ID: 17684491
[TBL] [Abstract][Full Text] [Related]
12. Expression of transforming growth factor alpha in normal human adult kidney and enhanced expression of transforming growth factors alpha and beta 1 in renal cell carcinoma.
Gomella LG; Sargent ER; Wade TP; Anglard P; Linehan WM; Kasid A
Cancer Res; 1989 Dec; 49(24 Pt 1):6972-5. PubMed ID: 2582439
[TBL] [Abstract][Full Text] [Related]
13. Transforming growth factor beta production and responsiveness in normal human melanocytes and melanoma cells.
Rodeck U; Bossler A; Graeven U; Fox FE; Nowell PC; Knabbe C; Kari C
Cancer Res; 1994 Jan; 54(2):575-81. PubMed ID: 8275496
[TBL] [Abstract][Full Text] [Related]
14. Human glioma-induced immunosuppression involves soluble factor(s) that alters monocyte cytokine profile and surface markers.
Zou JP; Morford LA; Chougnet C; Dix AR; Brooks AG; Torres N; Shuman JD; Coligan JE; Brooks WH; Roszman TL; Shearer GM
J Immunol; 1999 Apr; 162(8):4882-92. PubMed ID: 10202033
[TBL] [Abstract][Full Text] [Related]
15. Expression of TGF-beta 2 in human glioblastoma: a role in resistance to immune rejection?
Fontana A; Bodmer S; Frei K; Malipiero U; Siepl C
Ciba Found Symp; 1991; 157():232-8; discussion 238-41. PubMed ID: 1649035
[TBL] [Abstract][Full Text] [Related]
16. SD-208, a novel transforming growth factor beta receptor I kinase inhibitor, inhibits growth and invasiveness and enhances immunogenicity of murine and human glioma cells in vitro and in vivo.
Uhl M; Aulwurm S; Wischhusen J; Weiler M; Ma JY; Almirez R; Mangadu R; Liu YW; Platten M; Herrlinger U; Murphy A; Wong DH; Wick W; Higgins LS; Weller M
Cancer Res; 2004 Nov; 64(21):7954-61. PubMed ID: 15520202
[TBL] [Abstract][Full Text] [Related]
17. The role for transforming growth factor-beta (TGF-beta) in human cancer.
Gold LI
Crit Rev Oncog; 1999; 10(4):303-60. PubMed ID: 10654929
[TBL] [Abstract][Full Text] [Related]
18. TGF-beta1 acts as a tumor suppressor of human malignant keratinocytes independently of Smad 4 expression and ligand-induced G(1) arrest.
Paterson IC; Davies M; Stone A; Huntley S; Smith E; Pring M; Eveson JW; Robinson CM; Parkinson EK; Prime SS
Oncogene; 2002 Feb; 21(10):1616-24. PubMed ID: 11896591
[TBL] [Abstract][Full Text] [Related]
19. Distinct effects of human glioblastoma immunoregulatory molecules programmed cell death ligand-1 (PDL-1) and indoleamine 2,3-dioxygenase (IDO) on tumour-specific T cell functions.
Avril T; Saikali S; Vauleon E; Jary A; Hamlat A; De Tayrac M; Mosser J; Quillien V
J Neuroimmunol; 2010 Aug; 225(1-2):22-33. PubMed ID: 20493562
[TBL] [Abstract][Full Text] [Related]
20. Transforming growth factor beta signaling is disabled early in human endometrial carcinogenesis concomitant with loss of growth inhibition.
Parekh TV; Gama P; Wen X; Demopoulos R; Munger JS; Carcangiu ML; Reiss M; Gold LI
Cancer Res; 2002 May; 62(10):2778-90. PubMed ID: 12019154
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]